European Pharmaceutical Review

AUGUST 19, 2022

percent compound annual growth rate (CAGR) of the market include the increasing commercialisation of generics and emerging technologies and small biotechs with limited or no production capabilities driving development in the biopharmaceutical sector. According to the report, the packaging segment of the market will be worth $15.6

Packaging 98

Packaging Compounding 98

European Pharmaceutical Review

DECEMBER 21, 2022

Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

epicur

AUGUST 8, 2023

Implementation of GFI #256 Earlier this year, the FDA finalized regulatory guidance for compounded medications, known as GFI #256. If GFI is affecting your practice’s ability to get compounded medications for office use, partnering with a trusted 503B outsourcing facility can help you eliminate risks of limited ordering.

Compounding 52

Compounding Documentation Compounding Pharmacies Packaging 52